JP2008536867A5 - - Google Patents

Download PDF

Info

Publication number
JP2008536867A5
JP2008536867A5 JP2008506778A JP2008506778A JP2008536867A5 JP 2008536867 A5 JP2008536867 A5 JP 2008536867A5 JP 2008506778 A JP2008506778 A JP 2008506778A JP 2008506778 A JP2008506778 A JP 2008506778A JP 2008536867 A5 JP2008536867 A5 JP 2008536867A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
methoxy
pyridin
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008506778A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008536867A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/014194 external-priority patent/WO2006113498A2/en
Publication of JP2008536867A publication Critical patent/JP2008536867A/ja
Publication of JP2008536867A5 publication Critical patent/JP2008536867A5/ja
Pending legal-status Critical Current

Links

JP2008506778A 2005-04-14 2006-04-14 増殖疾患を処置する際に有用なｈｓｐ９０インヒビターとしての２−アミノ−キナゾリン−５−オン Pending JP2008536867A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67166205P 2005-04-14 2005-04-14
PCT/US2006/014194 WO2006113498A2 (en) 2005-04-14 2006-04-14 2-amino-quinaz0lin-5-ones as hsp90 inhibitors useful in treating proliferation diseases

Publications (2)

Publication Number Publication Date
JP2008536867A JP2008536867A (ja) 2008-09-11
JP2008536867A5 true JP2008536867A5 (enExample) 2009-06-04

Family

ID=37110373

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008506778A Pending JP2008536867A (ja) 2005-04-14 2006-04-14 増殖疾患を処置する際に有用なｈｓｐ９０インヒビターとしての２−アミノ−キナゾリン−５−オン

Country Status (12)

Country Link
US (1) US20070027150A1 (enExample)
EP (1) EP1885701A2 (enExample)
JP (1) JP2008536867A (enExample)
KR (1) KR20080006614A (enExample)
CN (1) CN101198596A (enExample)
AU (1) AU2006236557A1 (enExample)
BR (1) BRPI0609309A2 (enExample)
CA (1) CA2604942A1 (enExample)
MX (1) MX2007012836A (enExample)
RU (1) RU2007142007A (enExample)
TW (1) TW200718689A (enExample)
WO (1) WO2006113498A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2783B1 (en) * 2005-09-30 2014-03-15 نوفارتيس ايه جي Compounds 2-Amino-7, 8-dihydro-6H-Bayredo (3,4-D) Pyrimidine-5-Ones
WO2008033748A2 (en) 2006-09-11 2008-03-20 Curis, Inc. Quinazoline based egfr inhibitors containing a zinc binding moiety
CL2007002994A1 (es) * 2006-10-19 2008-02-08 Wyeth Corp Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
CN101225083A (zh) * 2007-01-16 2008-07-23 北京摩力克科技有限公司 四氢喹唑啉酮类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
WO2008132211A1 (en) * 2007-05-01 2008-11-06 Novartis Ag Amino-quinazolinone derivatives for use as radiotracers and imaging agents
ES2682108T3 (es) * 2007-05-17 2018-09-18 Athenex, Inc. Proceso para la preparación de composiciones para modular una cascada de quinasas y métodos de uso de estas
GB2449293A (en) * 2007-05-17 2008-11-19 Evotec Compounds having Hsp90 inhibitory activity
US8119616B2 (en) 2007-09-10 2012-02-21 Curis, Inc. Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety
EP2190287B1 (en) 2007-09-10 2014-10-29 Curis, Inc. Tartrate salts or complexes of quinazoline based egfr inhibitors containing a zinc binding moiety
TW200920357A (en) * 2007-09-10 2009-05-16 Curis Inc HSP90 inhibitors containing a zinc binding moiety
TW200922595A (en) * 2007-10-12 2009-06-01 Novartis Ag Organic compounds
MX2010006092A (es) * 2007-12-07 2010-07-05 Celgene Corp Biomarcadores para monitorear el tratamiento mediante compuestos de quinazolinona.
MY150596A (en) * 2008-02-01 2014-01-30 Takeda Pharmaceutical Hsp90 inhibitors
LT5623B (lt) 2008-04-30 2010-01-25 Biotechnologijos Institutas, , 5-aril-4-(5-pakeistieji 2,4-dihidroksifenil)-1,2,3-tiadiazolai kaip hsp90 šaperono slopikliai ir tarpiniai junginiai jiems gauti
WO2010042489A2 (en) * 2008-10-06 2010-04-15 Emory University Aminoquinoline derived heat shock protein 90 inhibitors, methods of preparing same, and methods for their use
DE102008061214A1 (de) 2008-12-09 2010-06-10 Merck Patent Gmbh Chinazolinamidderivate
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
CN101735119B (zh) * 2009-12-12 2013-03-27 浙江工业大学 一种三酮类化合物的合成方法
US8481459B2 (en) * 2010-06-14 2013-07-09 Academia Sinica Chemical inhibitors of ethylene biosynthesis
ITTO20111013A1 (it) 2011-11-03 2013-05-04 Dac Srl Composti farmaceutici
US9348490B2 (en) * 2012-09-14 2016-05-24 Ca, Inc. User interface with configuration, registration, and runtime selection of views
CN103333123B (zh) * 2013-07-17 2015-03-11 温州医科大学附属第二医院 一种二氢喹唑啉酮化合物的脱卤方法
CN112274250B (zh) * 2015-03-17 2024-12-31 直观外科手术操作公司 用于在远程操作医疗系统中呈现器械的屏幕识别的系统和方法
EP3459939A1 (en) * 2017-09-26 2019-03-27 Pragma Therapeutics Novel heterocyclic compounds as modulators of mglur7

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4723115B2 (ja) * 2001-05-23 2011-07-13 日本化薬株式会社 アデニル酸シクラーゼ５型阻害剤
AU2004236239A1 (en) * 2003-04-30 2004-11-18 The Institutes For Pharmaceutical Discovery, Llc Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
MXPA05013142A (es) * 2003-06-20 2006-03-17 Chiron Corp Compuestos de piridinio [1,2-a]pirimidin-4-ona como agentes anticancer.
US7138401B2 (en) * 2003-09-18 2006-11-21 Conforma Therapeutics Corporation 2-aminopurine analogs having HSP90-inhibiting activity
EP1773327A1 (en) * 2004-07-27 2007-04-18 Novartis AG Inhibitors of hsp90
PE20060572A1 (es) * 2004-07-27 2006-06-27 Novartis Ag Compuestos de benzoimidazolona como inhibidores de hsp90

Similar Documents

Publication Publication Date Title
JP2008536867A5 (enExample)
JP2009510108A5 (enExample)
JP2004536814A5 (enExample)
JP2003535828A5 (enExample)
AU2015353210B2 (en) 2-aminopyrimidine compound and pharmaceutical composition and use thereof
RU2007142007A (ru) 2-аминохиназолин-5-оны
JP2009534386A5 (enExample)
HRP20110655T1 (hr) 2-amino-7,8-dihidro-6h-pirido(4,3-d)pirimidin-5-oni, postupak njihove proizvodnje i farmaceutski sastavi koji ih sadrže
CN100358889C (zh) 咪唑-4-基-乙炔基-吡啶衍生物
WO2015015318A4 (en) Novel quinazolinones as bromodomain inhibitors
CA2571397A1 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
CN114430740A (zh) Egfr抑制剂、组合物及其制备方法
RU2005123484A (ru) Новые производные пиридазин-3(2н)-она
JP2010031025A5 (enExample)
CN1175414A (zh) 取代的氮杂环并嘧啶化合物,其药用盐或n－氧化物的制备方法
CA2671744A1 (en) Compounds and compositions as protein kinase inhibitors
CA2396590A1 (en) 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors
CA2568725A1 (en) Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists
TW200534853A (en) Synergistic methods and compositions for treating cancer
RU2018131766A (ru) 6-гетероциклил-4-морфолин-4-илпиридин-2-оны, пригодные для лечения рака и диабета
RU2018131775A (ru) 6-арил-4-морфолин-1-илпиридоны, пригодные для лечения рака или диабета
JP2016522231A5 (enExample)
JP2015526452A5 (enExample)
JP2019505595A5 (enExample)
CA2461916A1 (en) Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis